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Sub-Saharan Africa is home to 90% of HIV infected (HIV+) children. Since the advent
of antiretroviral therapy (ART), HIV/AIDS has transitioned to a chronic condition where
central nervous system (CNS) damage may be ongoing. Although, most guidelines
recommend early ART to reduce CNS viral reservoirs, the brain may be more vulnerable
to potential neurotoxic effects of ART during the rapid development phase in the first
years of life. Here we investigate differences in subcortical volumes between 5-year-old
HIV+ children who received early ART (before age 18 months) and uninfected children
using manual tracing of Magnetic Resonance Images. Participants included 61 Xhosa
children (43 HIV+/18 uninfected, mean age = 5.4 ± 0.3 years, 25 male) from the
children with HIV early antiretroviral (CHER) trial; 27 children initiated ART before 12
weeks of age (ART-Before12Wks) and 16 after 12 weeks (ART-After12Wks). Structural
images were acquired on a 3T Allegra MRI in Cape Town and manually traced using
MultiTracer. Volumetric group differences (HIV+ vs. uninfected; ART-Before12Wks vs.
ART-After12Wks) were examined for the caudate, nucleus accumbens (NA), putamen
(Pu), globus pallidus (GP), and corpus callosum (CC), as well as associations within
infected children of structure volumes with age at ART initiation and CD4/CD8 as a
proxy for immune health. HIV+ children had significantly larger NA and Pu volumes
bilaterally and left GP volumes than controls, whilst CC was smaller. Bilateral Pu was
larger in both treatment groups compared to controls, while left GP and bilateral NA
were enlarged only in ART-After12Wks children. CCwas smaller in both treatment groups
compared to controls, and smaller in ART-After12Wks compared to ART-Before12Wks.
Within infected children, delayed ART initiation was associated with larger Pu volumes,
effects that remained significant when controlling for sex and duration of treatment
interruption (left β = 0.447, p = 0.005; right β = 0.325, p = 0.051), and lower
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CD4/CD8 with larger caudates controlling for sex (left β = −0.471, p = 0.002; right
β = −0.440, p = 0.003). Volumetric differences were greater in children who initiated
ART after 12 weeks. Results suggest damage is ongoing despite early ART and viral
load suppression; however, earlier treatment is neuroprotective.
Keywords: HIV/AIDS, antiretroviral, MRI, volumetric segmentation, WM, GM, pediatric
INTRODUCTION
Since the advent of combination antiretroviral (ARV) therapy
(ART), human immunodeficiency virus (HIV) infection has
become a chronic condition with ongoing damage to the body
and central nervous system (CNS), especially in the developing
brain of the fetus, infant and young child (van Rie et al., 2007).
As CNS penetration by ART is limited, the brain may become a
reservoir for the virus, with few drugs available to impact these
reservoirs (van Rie et al., 2007). Substantial brain development
in the first few years of life puts infected children at greater
risk of neurological impairment compared to HIV infected
(HIV+) adults (Tardieu et al., 2000; Mitchell, 2001). For example,
language functions are more impaired in HIV+ children than in
adults (van Rie et al., 2007).
To minimize effects of HIV in children, new guidelines
recommend that life-long ART be initiated as soon as
possible (WHO, 2013). However, some ARVs can cause
neurodevelopmental impairment despite virological suppression
in the CNS (Tardieu et al., 2005; van Rie et al., 2007). For
example, prenatal exposure to zidovudine has been linked to
mitochondrial dysfunction within the CNS (Tardieu et al., 2005),
as well as chronic ARV treatment in the form of combination
therapy results in abnormal BOLD response within frontal brain
regions (Chang et al., 2008). Few studies have examined the
long-term neurological effects of HIV infection in children in
whom plasma viral loads (VL) are suppressed following early
ART (before 18 months of age; Le Doaré et al., 2012; Laughton
et al., 2013; Phillips et al., 2016), and very little is known about the
complex nature of brain recovery following ART initiation and
subsequent brain development (Tamula et al., 2003; Shanbhag
et al., 2005; van Rie et al., 2007; Govender et al., 2011; Laughton
et al., 2012; Whitehead et al., 2014).
Although neuroimaging can provide insights into the
mechanisms underpinning neurobehavioral outcomes in HIV+
children (Hoare et al., 2014; Musielak and Fine, 2016), such
studies are rare, even in developed countries, and have typically
included children across wide age ranges who either started
ART late (Hoare et al., 2015) or some on early ART but small
numbers with VL suppression (van Arnhem et al., 2013; Sarma
et al., 2014). Studies in children and youths where most (>85%)
have suppressed viral loads, and some received early ART, have
demonstrated lower global and local cortical and total gray
matter (GM) volumes (Cohen et al., 2016; Lewis-de Los Angeles
et al., 2017), white matter (WM) alterations (Ackermann et al.,
2014, 2016; Andronikou et al., 2014; Uban et al., 2015), and
volume reductions (Cohen et al., 2016), both subcortical volume
increases and decreases and shape deformations (Lewis-de Los
Angeles et al., 2016; Yadav et al., 2017), altered cortical thickness
(Yadav et al., 2017), and effects of immunocompromise in infancy
on basal ganglia metabolism at 5 years (Mbugua et al., 2016).
These findings suggest that HIV- and/or ART-related damage
may be irreversible or ongoing.
In this study we compare over a narrow age range (4.9–
6.5 years of age) manually traced volumes of select subcortical
structures and the corpus callosum in a unique cohort of HIV-
infected children, all of whom initiated ART before 76 weeks of
age and were followed since birth, to HIV-uninfected children
from the same community. This is the first study using gold-
standard manual tracing (Morey et al., 2009) to assess structural
brain changes in perinatally acquired HIV on early ART (Hoare
et al., 2014; Musielak and Fine, 2016). Amongst HIV+ children
from this cohort, initiating treatment before 12 weeks showed
improved cognitive performance at 11 months and improved
overall health compared to starting treatment after 12 weeks
(Violari et al., 2008; Laughton et al., 2012; Cotton et al., 2013).
We also examined the effect of timing of treatment initiation
on volume alterations. We hypothesized that HIV+ children on
early treatment would experience similar perturbations observed
previously in both children and adults, with neuronal thinning,
resulting overall in global atrophy and loss of gray matter and
white matter volume. In addition, we hypothesized that earlier
treatment would mitigate the effects of HIV and accompanying
brain damage leading to smaller reductions in volume in children
initiating ART earlier.
MATERIALS AND METHODS
This study included 43 HIV+ Xhosa children from the
randomized CHER (Children with HIV early antiretroviral)
trial in follow-up at the Children’s Infectious Diseases Clinical
Research Unit, Tygerberg Children’s Hospital, Cape Town
(Laughton et al., 2012). As part of the CHER trial, infants with
CD4 percentage (CD4%) of at least 25% were randomized to one
of the following three treatment arms: ART-Def (ART Deferred
until CD4% < 25% in first year or CD4% < 20% thereafter,
or if clinical disease progression criteria presented); ART-40W
(ART initiated before 12 weeks of age and interrupted after 40
weeks); and ART-96W (ART initiated before 12 weeks of age
and interrupted after 96 weeks). ART was restarted in ART-
40W and ART-96W for CD4% decline or clinical evidence of
disease progression. (Violari et al., 2008; Cotton et al., 2013).
One child not adhering to ART was excluded. Since some
children in the ART-Def arm met criteria for almost immediate
initiation of ART, the children were grouped here based on age
at treatment initiation, specifically those who received ART at
or before 12 weeks (ART-Before12wks) and those who received
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treatment after 12 weeks (ART-After12wks). Of the 27 who
received ART before 12 weeks, 9 remained on continuous ART in
line with clinical criteria governing interruption. Treatment was
interrupted in 18, two of whom had not met ART restart criteria
at the time of scan as they remained clinically well with CD4% of
at least 20%.
Eighteen HIV uninfected Xhosa children were recruited from
an interlinked vaccine trial as controls (Madhi et al., 2010). They
comprised 12 HIV exposed uninfected (HEU) children born to
HIV+ mothers but who tested HIV negative (PCR) at baseline
and 30 days after the third dose of vaccine, and 6 HIV unexposed
and uninfected children (HU) born to HIV seronegative mothers
(tested after 24 weeks gestation) who remained seronegative at
enrolment.
All children received MRI scanning on a 3T Allegra MRI
(Siemens, Erlangen, Germany) at the Cape Universities Brain
Imaging Centre (CUBIC) according to protocols approved by
the Human Research Ethics Committees of the Universities
of Cape Town and Stellenbosch. All parents provided written
informed consent and all children provided oral assent. High-
resolution T1 weighted images were acquired using a volumetric
echo-planar imaging (EPI) navigated (Tisdall et al., 2012) multi
echomagnetization prepared rapid gradient echo (MEMPRAGE)
sequence (van der Kouwe et al., 2008). Imaging parameters
were: FOV: 224 × 224 mm2; 144 sagittal slices, TR: 2,530ms;
TE: 1.53/3.19/4.86/6.53ms; TI: 1,160ms; Flip angle: 7◦; voxel
size: 1.3 × 1.0 × 1.0 mm3, scan time 5:20min. The 3D EPI
navigator provided real-time motion tracking and correction.
BrainVoyager QX software (Brain Innovation, Maastricht) was
used to transform DICOM files into the AC-PC plane and rotate
images for hemispherical symmetry.
Due to its frequency in the HIV literature, the basal ganglia
(Figure 1A) was the primary subcortical region of interest
(ROI), with the corpus callosum (Figure 1B) functioning as
the white matter analog. All gray matter structures within the
basal ganglia were manually segmented, with the exception of
the substantia nigra and subthalamic nuclei. The structures
included the caudate head, nucleus accumbens (NA), globus
pallidus (GP), and putamen (Pu). All structures were manually
traced using MultiTracer software (http://bishopw.loni.ucla.edu/
MultiTracer/) on a Lenovo ThinkPad X200 tablet and integrated
active digitizer stylus.
All tracings were performed at 4X magnification as further
magnification resulted in visible pixelation of the images. Image
files were scaled according to the prescribed voxel intensity
range (Woods, 2003); the contrast used in this study ranged
from Pixel Intensity Units of 13,000 to 18,000 dependent on
the structure. Screen brightness for the tracing tablet was set
to 100% and brightness of images was set to 1.34 (49% of
a maximum unadjusted default scale value of 2.72) for most
structures (Woods, 2003).
The contours of selected brain structures were completed
by manually outlining the structures on MR images, slice by
slice. For standardization purposes, tracing of all subcortical gray
matter structures were performed in the coronal plane. Based on
this tracing, we present the frust volumes output by MultiTracer.
The expert neuroanatomist (SR) who performed all tracings
was blinded to all participant data. Inter-rater and intra-rater
reliabilities were assessed for each structure using independent
measurements for 10 participants who were randomly selected
by another expert neuroanatomist (CW) and the primary tracer
(SR), respectively, and assessed via Pearson and intra-class
correlation.
Data and statistical analyses were performed in IBM SPSS
Statistics 23. ANOVA was used to compare structure volumes
of uninfected children to infected children, and to children
who initiated ART before and after 12 weeks. Additionally,
amongst infected children, we used linear regression to examine
associations of structure volumes with timing of ART initiation.
Since treatment was interrupted in a subset of the children who
received ART before 12 weeks and interruption is characterized
by a subsequent drop in CD4 cell count and increased VL,
FIGURE 1 | (A) Coronal view showing the four different structures that were manually segmented in the basal ganglia, namely the caudate (red), putamen (green),
globus pallidus (magenta), and nucleus accumbens (blue). (B) Sagittal view showing a tracing of the corpus callosum in a midline slice (yellow).
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which may negate the potential benefits of earlier ART, multiple
regression was used to control for duration of interruption.
Duration of interruption was set to zero for children in whom
treatment was not interrupted. Sex was controlled for in all
analyses as it affects brain development (Gur et al., 1999; Gilmore
et al., 2007). Finally, to explore whether volume alterations may
be due to an inflammatory response, we examined relationships
between structure volumes and CD4/CD8 ratio as a proxy for
immune health, both at enrolment and at scan. Due to the fact
that statistical analyses were repeated for 9 anatomical structures,
we indicate for each test which results survive Bonferroni
correction (p< 0.0056).
Since lower total GM and WM volumes have been
reported in HIV+ youths (Cohen et al., 2016; Lewis-de
Los Angeles et al., 2017), total intracranial volumes (ICVs)
were derived for all children using FreeSurfer (Fischl, 2012)
and considered a potential confounder. Additional control
variables considered included age at scan and birthweight.
Control variables showing group differences were controlled
for using analysis of covariance (ANCOVA) and multiple
regression.
RESULTS
We present data for 61 Xhosa children (mean age ± s.e. =
5.4 ± 0.04; 25 male). Of 18 uninfected controls, 12 were HEU
and 6 HU. Of the 43 infected children, 27 received ART before
12 weeks, and 16 after. Sample characteristics are summarized
in Table 1. Since uninfected children were slightly older than
infected children, and children who received ART before 12
weeks had smaller ICVs than uninfected controls, we controlled
for ICV and age at scan in all analyses involving uninfected
and infected children. While no children had suppressed VLs
at enrolment, VL was suppressed in 93% of infected children at
time of scanning. Children receiving ART before and after 12
weeks did not differ on any of the clinical variables. No significant
effect of interruption on structure volume was observed, nor
did duration of interruption show any relation with structure
volumes (all p’s> 0.18).
All inter-rater Pearson correlations for manually traced
volumes were significant (all p’s < 0.05) and ranged from r =
0.71 for the left caudate to r = 0.93 for the corpus callosum.
Cronbach’s α’s were above 0.8 in all regions. Intra-rater Pearson
correlations were greater than r = 0.82 (all p’s < 0.001), and
Cronbach’s α’s were all above 0.83.
In Table 2 we compare structure volumes between HIV+
and uninfected children, and in Figure 2 between uninfected
children and children who received ART before and after 12
weeks, controlling for sex, ICV, and age at scan. Infected children
showed gray matter (GM) volume increases in left (L) NA, albeit
below conventional levels of significance, right (R) NA, bilaterally
in Pu, and L GP, effects that appear to be largely attributable
to volume increases in children who initiated ART after 12
weeks. In contrast to GM volume increases, CC was smaller
in infected children with reductions evident both in children
initiating ART before and after 12 weeks. Only in CC did volumes
differ significantly between children initiating ART before and
after 12 weeks, with the latter showing greater volume reductions
compared to uninfected controls than children who initiated
ART before 12 weeks. HIV-related volume increases in the Pu
and reductions in the CC remain significant after Bonferroni
correction for multiple comparisons.
Amongst infected children, increasing age of ART initiation
was associated with larger Pu volumes bilaterally (Figure 3,
Table 3), with the association on the left surviving Bonferroni
correction for multiple comparisons. Although caudate volumes
did not show any group differences or relation with timing of
ART initiation, amongst infected children, lower CD4/CD8 ratio
at the time of scanning was associated with caudate volume
increases bilaterally (left r = −0.487, p = 0.007; right r =
−0.469, p = 0.001; Figure 4), effects that remained significant
when controlling for sex (left β = −0.471, p = 0.002; right β
= −0.440, p = 0.003) and adjusting for multiple comparisons.
Lower enrolment CD4/CD8 was also weakly associated with
greater caudal volumes at age 5 years (left r = −0.252 p = 0.107;
right r = −0.298 p = 0.056), although these relations did not
survive when controlling for sex (left β =−0.217, p= 0.201; right
β = −0.226, p = 0.172). No other regions showed association
between volumes and immune health at enrolment (all p’s> 0.2)
or at scan (all p’s> 0.5).
DISCUSSION
This is the first study to examine over a narrow age range the
impact of HIV on subcortical gray matter and corpus callosum
volumes in a cohort of children receiving ART before 18 months
of age and VL suppression by 109 weeks in all but three children.
In contrast to most previous studies in HIV+ adults and children
that reported gray matter atrophy (Tardieu et al., 2000; Crain
et al., 2010; Becker et al., 2011; Chang et al., 2011; Cohen et al.,
2016; Musielak and Fine, 2016; Lewis-de Los Angeles et al.,
2017), we found HIV-related subcortical GM volume increases
at 5 years in the left GP and bilaterally in the NA and Pu, but
CC reductions. Association of increasing age of ART initiation
with greater volumes in the Pu suggest that treatment timing
plays a role in these observed volume increases. The fact that
both GM and WM volume differences were largest in children
who initiated ART after 12 weeks point to greater protection
from earlier treatment, which is consistent with the findings from
other studies in this cohort (Laughton et al., 2012; Mbugua et al.,
2016). The fact that associations of Pu and NA volumes with
treatment timing strengthened after adjustment for interruption
supports findings from a previous DTI study in the same cohort
that found the lowest fractional anisotropy in a region in the
corticospinal tract in treatment-interrupted children suggesting
that ART interruption may negate the benefit of earlier ART
(Ackermann et al., 2016).
Even though most studies in children find cortical and
total gray matter atrophy in HIV infection (Cohen et al.,
2016; Lewis-de Los Angeles et al., 2017), regional GM volume
increases have been reported (Sarma et al., 2014). Although,
few studies have examined subcortical volumes specifically, two
recent studies reported HIV-related regional subcortical GM
increases. Blokhuis et al. (2017) found trend-level Pu increases
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TABLE 2 | Comparison of structure volumes between HIV infected and uninfected
children.
ROI (mm3) Uninfected Controls (n = 18) HIV infected (n = 43) F p
Mean (SD) Mean (SD)
L Caudate 4,045 (551) 4,065 (419) 0.312 0.58
R Caudate 4,216 (527) 4,253 (418) 0.904 0.35
L NA 520 (124) 587 (127) 3.587 0.06
R NA 556 (107) 620 (118) 5.205 0.03
CC 470 (71) 357 (65) 19.216 <0.001
L Pu 4,892 (578) 5,246 (516) 15.768 <0.001
R Pu 4,897 (530) 5,272 (518) 18.097 <0.001
L GP 1,804 (166) 1,852 (210) 3.907 0.05
R GP 1,818 (181) 1,816 (215) 2.016 0.16
F-value from Analysis of Covariance adjusted for sex, intracranial volume and age at scan.
TABLE 3 | Associations in infected children of structure volume with age at ART
initiation.
ROI Association with Age at ART Initiation
(n = 43)
r p β1 p β2 p
L Caudate 0.071 0.651 0.060 0.701 0.193 0.230
R Caudate 0.150 0.336 0.134 0.380 0.227 0.161
L NA 0.272 0.078 0.269 0.085 0.296 0.080
R NA 0.230 0.138 0.235 0.133 0.286 0.091
CC −0.030 0.847 −0.038 0.808 0.016 0.924
L Pu 0.398 0.007 0.385 0.010 0.447 0.005
R Pu 0.295 0.055 0.288 0.063 0.325 0.051
L GP 0.256 0.098 0.240 0.113 0.233 0.155
R GP 0.209 0.178 0.193 0.204 0.264 0.104
r is the Pearson correlation coefficient; β1 is the standardized regression coefficient
adjusted for sex; β2 is the standardized regression coefficient adjusted for sex and
duration of interruption.
in HIV+ children, and Yadav and colleagues larger nucleus
accumbens and smaller hippocampi (Yadav et al., 2017). The
authors postulated inflammatory processes and chronic stress
as possible explanations for the volume increases. Putamen
hypertrophy in HIV+ adults has also been attributed to possible
inflammation and dopaminergic system dysfunction (Castelo
et al., 2007). The absence of association of CD4/CD8 ratio, as
a marker of immune health, with volumes in regions showing
HIV-related increases in our study, suggest that observed volume
increases are not necessarily due to inflammatory processes in
these specific regions.
Compared to the relative abundance of literature attributing
structural atrophy to gliosis and inflammation (Bates et al.,
2002; Miller et al., 2002; Mehta et al., 2003; Pekny and
Pekna, 2016; Pérez-Cerdá et al., 2016), the mechanisms for
pathology-induced hypertrophy of brain structures are not well-
understood. Although enlargement of the striatum has been
associated with dopaminergic system dysfunction in recreational
and antipsychotic drug use (Selemon et al., 1999; Jacobsen
et al., 2001; Dazzan et al., 2005; Jernigan et al., 2005), and
linked specifically to elevated glial densities in rhesus monkeys
administered antipsychotic drugs (Selemon et al., 1999), smaller
volume differences in children who initiated ART earlier in our
study suggests that the gray matter hypertrophy observed here is
not due to gliosis resulting from ART drug interactions. Notably,
gray matter hypertrophy has been observed in patients with
obstructive sleep apnea (Rosenzweig et al., 2013). Since short-
term hypoxic events have been shown to induce reactive gliosis
and neuronal death in rats (Aviles-Reyes et al., 2010), ischaemic
preconditioning may cause long-lasting neuronal changes within
the brain. This may be relevant here as cerebrovascular
alterations have been reported in HIV+ children (Shah et al.,
1996; Patsalides et al., 2002). Increased metabolic demand in the
presence of reactive gliosis (Epstein and Gelbard, 1999; Walsh
et al., 2004) and mitochondrial dysfunction in HIV+ children
(Tardieu et al., 2005; Crain et al., 2010; Takemoto et al., 2017)
may create localized subclinical ischaemic/hypoxic stress within
the CNS. Angiogenesis from ischaemic preconditioning may be
exacerbated by the HIV-Tat gene, a heparin-binding angiogenic
growth factor (Das et al., 2016), expressed by infected cells. The
exact mechanisms of gray matter hypertrophy in HIV+ children
requires further investigation.
Volumetric MRI studies in HIV have mostly relied on
automated/semi-automated techniques (Hoare et al., 2014;
Sarma et al., 2014; Musielak and Fine, 2016), which typically
involve some form of co-registration to a template based on an
adult brain, using contrast or other feature discriminators. These
techniques may be suboptimal for diagnoses where regional
or global brain volumes may be affected, or when examining
children. It has been shown that using age-matched pediatric
brain templates in pediatric studies lead to considerably different
tissue distribution from that obtained with an adult-based
template (Yoon et al., 2009). This may explain why previous
studies of subcortical volumes using FreeSurfer either failed to
detect group differences (Lewis-de Los Angeles et al., 2016), or
detected fewer and less significant differences (Blokhuis et al.,
2017; Yadav et al., 2017) than in our study. Using FreeSurfer
automated segmentation in our cohort, within the gray and
white matter structures investigated, there were no significant
volumetric differences between groups, apart from the left globus
pallidus (GP) which was smaller in infected children (L GP:Mean
(SD): HIV 1,775 ± 192 mm3, controls 1,949 ± 255 mm3, F =
7.848, p = 0.007), and the CC that tended to be larger (HIV 469
± 89 mm3, controls 431 ± 68 mm3, F = 2.871, p = 0.096). In
both structures, the findings were opposite to those generated
using manual segmentation, indicating that automated methods
may be inappropriate for pediatric populations, especially in the
presence of pathology, and that manual segmentation may be
more sensitive to detect subtle changes.
The highest concentration of HIV is observed in the caudate
nuclei and CC (Thompson et al., 2006; Ances et al., 2012),
possibly due to their proximity to the ventricles. The proximity of
these structures to the ventricles, and thus CSF, allows for easier
penetration of HIV-infectedmononuclear cells permitting higher
concentrations of HIV toxins in these sites (Oster et al., 1993;
McClernon et al., 2001; Thompson et al., 2006; Kumar et al.,
2007; Ances et al., 2012; Andronikou et al., 2014). This would
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FIGURE 2 | Mean and confidence interval of structure volumes in children who initiated ART before and after 12 weeks and uninfected controls. Volumes were
compared using ANCOVA adjusted for sex, intracranial volume, and age at scan. (A) Caudate (B) nucleus accumbens (NA) (C) Putamen (Pu) (D) Globus pallidus (GP)
(E) Corpus callosum (CC) (L, left; R, right); *p < 0.05, **p < 0.01, ***p < 0.001.
in turn also apply to certain ARVs that more readily permeate
through the blood-brain-barrier (BBB) and pass within the CSF
to these sites. As such, location may explain the association seen
in the left and right caudate with CD4/CD8 ratio at the time
of scanning as a measure of immune health in which the more
immunocompromised children at the time of scan had larger
caudate volumes bilaterally. This relationship, which survives
correction for multiple comparisons, suggests that at this age
the caudate is particularly susceptible to the concurrent immune
state.
Due to their greater distance from the ventricles, the Pu
and NA may be less readily penetrated by the HIV-infected
mononuclear cells. However, higher cerebral blood flow of these
areas have been observed in HIV+ children (Blokhuis et al.,
2017). Another hypothesis may be that once HIV invades the
area and viral infection spreads, removal of metabolic waste
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FIGURE 3 | Plots showing the association of volume in the left (Top) and right (Bottom) putamen with age of ART initiation. The box plot on the right indicates the
median volume and IQR for uninfected controls in the same age range as the infected children.
and virions may be slower in these structures compared to the
caudate. This may explain the larger Pu and NA observed in
HIV+ children. Thus, presence of inflammation in the form of
reactive gliosis and leukocyte infiltration, resulting in slightly
increased structure size, may be because of prolonged HIV
exposure in the Pu and NA rather than a present acute, transient,
and compromised immunological state, as in the left and right
caudate.
Our finding of reduced CC volume in HIV infection is
consistent with that of most previous studies (Thompson et al.,
2006; Chiang et al., 2007; Hasan et al., 2009; Dewey et al., 2010;
Heaps et al., 2012; Hoare et al., 2012; Sarma et al., 2014; Yadav
et al., 2017), although CC volume and thickness were similar
to those in controls in a study by Andronikou et al. (2015)
including infected children from the same cohort studied here.
In our study, the largest volume difference between infected and
uninfected children was observed in the CC, with the CC of
HIV+ children being on average 24% smaller at 5 years of age
than in their uninfected counterparts. Thompson et al. (2006),
who similarly found a 25% decrease in the thickness of the CC
in HIV+ adults compared to uninfected controls (Thompson
et al., 2006), postulated that the overall thickness of the CC is
impacted by the loss of peripheral WM. It has been suggested
that callosal thickness and volume may be used as biomarkers of
overall global WM integrity (Thompson et al., 2006; Andronikou
et al., 2014). However, DTI in children from the same cohort
studied here revealed no differences in WM integrity between
infected and uninfected children in the CC at 5 years of age
(Ackermann et al., 2016), despite volume reductions. Since DTI
analyses involve co-registration to a template before performing
voxel wise statistical comparisons, DTI outcomes would not be
impacted by volume differences. As such, making inferences
regarding microstructural integrity from macrostructural data
may be inappropriate.
The clinical manifestations of HIV infection in these children
do not paint a clear picture of causation. VL was suppressed
(≤399 RNA/ml) in 93% of children at time of scanning. A
previous study in 128 perinatally infected children, who were
born prior to the adoption of preventative treatment or ART
guidelines, found that 21% showed characteristic evidence of
HIV infection induced encephalopathy, despite at least 74% of
these children having VL suppression at the time of diagnosis
(Cooper et al., 1998). Findings of VL suppression in plasma may,
however, not be representative of the compartmentalized and
unique viral reservoirs in the CNS (Strain et al., 2005; Pillai et al.,
2006). Further, there could be ongoing effects from damage or
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FIGURE 4 | Association of left (Top) and right (Bottom) caudal volumes with CD4/CD8 ratio at scan as a proxy for immune health. The box plot indicates the
distribution of caudate volumes in healthy uninfected controls, excluding the 6 children older than 6 years to match the age range of the uninfected children.
delayed development arising during the initial phases of HIV
invasion, prior to ART initiation, which may have occurred
in utero in some participants. In our study, all HIV+ treatment
groups had elevated VL at study entry (7 weeks of age) thus
possibly facilitating HIV entry into the CNS early on (Ivey
et al., 2009). Neuroinvasion by HIV can occur as early as the
initial 10 days post-infection (Lackner et al., 1994). Early ART
administered at around 8.4 ± 1.6 weeks of age is perhaps too
late for individuals already experiencing high viral loads. Damage
to the basal ganglia, and thus corpus striatum is dictated by
the rate of initial insult (Brouwers et al., 2000; Becker et al.,
2011). This may be evidenced by our observation of CD4/CD8
ratio at enrolment showing weak trend-like association with the
size of the left and right caudate. This ties in with spectroscopy
findings involving the same cohort at the same age, where basal
ganglia metabolite levels (choline, NAA) were associated with
CD4/CD8 at enrolment, suggesting that early infiltration and
damage caused by HIV persists into early childhood (Mbugua
et al., 2016). A confounding issue here may be the duration
of ART itself. A trend of duration of ART with prefrontal CC
thickness was observed in this cohort previously (Ackermann
et al., 2014; Andronikou et al., 2014). It has also been shown that
ART decreases motor and working memory performance in both
children and adults (von Giesen et al., 2003; Chang et al., 2008;
Laughton et al., 2012) which suggests that there may be some
complicated interplay between the benefits and risks associated
with early ART.
A limitation to the study is the inclusion of total ICV
calculated using FreeSurfer automated methods. Intrinsically,
using an automated measure to standardize manually derived
volumes may add to inaccuracies (Morey et al., 2009; Yoon
et al., 2009; Dewey et al., 2010; Narayanan et al., 2016). However,
our results do not change significantly without the inclusion of
ICV. In addition, a limitation in sampling bias may exist. As
the HIV+ Xhosa children formed part of a longitudinal cohort
followed since birth with regular follow-up visits to the clinic, it
is possible that they are at an added advantage as they could be
receiving better health care than the normal standard community
care, despite standardized treatment as per the current WHO
guidelines. These children also received neuropsychological
and behavioral testing giving them additional opportunities
for individual case specific and HIV-related support. Children
who maintained participation may also have nuanced home
environments which allowed them to continue longitudinally.
Overall findings of this study suggest that perinatal HIV
infection targets select structures of the basal ganglia, and that
these effects are observable at 5 years of age despite early ART
and VL suppression. In HIV+ children, both the NA and Pu are
enlarged bilaterally, as well as the left GP. In contrast, the CC
is smaller compared to uninfected children. Our results suggest
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that earlier treatment is neuroprotective. Early therapy before
severe viral replication would be advantageous, as evidenced by
increased structure size of the bilateral Pu with increased delay to
initiate ART.
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